ANI PHARMACEUTICALS, INC Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ANI PHARMACEUTICALS, INC stock issued during period, value, new issues for the quarter ending 2023-12-31 was $0.00.
- ANI PHARMACEUTICALS, INC stock issued during period, value, new issues for the quarter ending 2023-09-30 was $0.00.
- ANI PHARMACEUTICALS, INC stock issued during period, value, new issues for the quarter ending 2023-06-30 was $80.56M.
- ANI PHARMACEUTICALS, INC stock issued during period, value, new issues for fiscal 2023 was $80.56M.
- ANI PHARMACEUTICALS, INC stock issued during period, value, new issues for fiscal 2021 was $69.73M.
- ANI PHARMACEUTICALS, INC stock issued during period, value, new issues for fiscal 2014 was $46.68M.
- ANI PHARMACEUTICALS, INC stock issued during period, value, new issues for fiscal 2011 was $44.96M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $80.56M 10-K · filed 2026-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | |
| 2023-06-30 | $80.56M 10-Q · filed 2024-08-06 | |
| 2021-12-31 | $69.73M 10-K · filed 2024-02-29 | |
| 2014-12-31 | $46.68M 10-K · filed 2017-03-02 | |
| 2011-12-31 | $44.96M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |